These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5341425)

  • 21. [Effect of xanthinol-nicotinate on the metabolism in diabetics].
    Pröls H; Haslbeck M
    Ther Ggw; 1974 Jul; 113(7):1194-6, 199-200, 202 passim. PubMed ID: 4612854
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of pharmacological treatment of psychosis].
    Gottfries CG
    Lakartidningen; 1973 Jul; 70(28):2582-5. PubMed ID: 4595435
    [No Abstract]   [Full Text] [Related]  

  • 23. Nicotinic acid in the treatment of schizophrenia.
    Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with Cosaldon retard in double blind studies].
    Dreyer H; Keussen M; Wojtek L
    Dtsch Med J; 1969 May; 20(10):356-8. PubMed ID: 4919479
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and psychological experience with a geratric drug].
    Bruck J; Maly J; Quatember R; Tschabitscher H
    Wien Med Wochenschr; 1972 Dec; 122(50):747-53. PubMed ID: 4568234
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy and clinical trials: nicotinic acid in the management of atherosclerotic disease.
    Udiawar MV; Rees A
    Curr Opin Lipidol; 2010 Jun; 21(3):286-8. PubMed ID: 20463477
    [No Abstract]   [Full Text] [Related]  

  • 28. On-going national collaborative studies in Canada: niacin in the treatment of schizophrenias.
    Ban TA
    Psychopharmacol Bull; 1969 Jul; 5(3):5-20. PubMed ID: 4906584
    [No Abstract]   [Full Text] [Related]  

  • 29. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study.
    Hoffer A
    Int J Neuropsychiatry; 1966 Jun; 2(3):234-40. PubMed ID: 4225426
    [No Abstract]   [Full Text] [Related]  

  • 31. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia.
    Vallely JF; Lovegrove TD; Hobbs GE
    Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335
    [No Abstract]   [Full Text] [Related]  

  • 32. Nicotinic acid: new/old drug. Immediate or sustained release: too risky for a drug with no proven benefit.
    Prescrire Int; 2006 Dec; 15(86):213-6. PubMed ID: 17165243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled study of neuroleptization with fluphenazine hydrochloride injections.
    Escobar JI; Barron A; Kiriakos R
    J Clin Psychopharmacol; 1983 Dec; 3(6):359-62. PubMed ID: 6139394
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of Ru-Vert and its components on post-rotatory motor performance.
    Lynes TE; Boos LE
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):937-44. PubMed ID: 4214669
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse effects of niacin in emergent psychosis.
    Hoffer A
    JAMA; 1969 Feb; 207(7):1355. PubMed ID: 4885414
    [No Abstract]   [Full Text] [Related]  

  • 37. Litonit: evaluation of clinical effectiveness.
    Kresyn VI; Aryaev VL; Kostev FI
    Alcohol Alcohol; 1993 May; 28(3):333-7. PubMed ID: 8352844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enantaldehydes and furaldehydes in molimina crurum nocturna including "restless legs". A comparative trial with carbacholine, inositolnicotinate, and placebo].
    Brenning R
    Nord Med; 1969 Apr; 81(17):528-34. PubMed ID: 4889762
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complamin in senile dementias. Report on a double-blind study with negative results].
    Robak OH
    Nord Psykiatr Tidsskr; 1967; 21(4):341-6. PubMed ID: 4873336
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mental disorders treated with iproniazide].
    BUENTELLO Y VILLA E
    Medicina (Mex); 1958 Aug; 38(802):388-91. PubMed ID: 13589444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.